Elicio Therapeutics, Inc.
ELTX • NASDAQ
Elicio Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert T. Connelly, with a market cap of $192.1M.
CEORobert T. Connelly
Next Earnings
Upcoming earnings announcement for Elicio Therapeutics, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.49
Earnings History
Past 11 earnings reports for Elicio Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | -$0.45Est: -$0.46 | +2.2% | - | — |  10-K |
| Nov 13, 2025 | Q3 2025 | -$0.60Est: -$0.54 | -11.1% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.66Est: -$0.69 | +4.3% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.87Est: -$0.82 | -6.1% | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$1.02Est: -$0.88 | -15.9% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$1.39Est: -$0.81 | -71.6% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.64Est: -$0.96 | +33.3% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$1.15Est: -$1.21 | +5.0% | - | — | 10-Q |
| Mar 29, 2024 | Q4 2023 | -$3.77Est: -$0.78 | -383.3% | - | — | 10-K/A |
| Nov 9, 2023 | Q3 2023 | -$1.27 | — | - | — | — |
| Aug 11, 2023 | Q2 2023 | -$2.61 | — | - | — | — |